BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2022 8:46:12 AM | Browse: 378 | Download: 933
 |
Received |
|
2021-10-11 20:22 |
|
Peer-Review Started |
|
2021-10-11 20:24 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-15 22:51 |
|
Revised |
|
2022-01-13 18:43 |
|
Second Decision |
|
2022-03-18 06:12 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-03-26 21:52 |
|
Articles in Press |
|
2022-03-26 21:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-03-14 22:13 |
|
Typeset the Manuscript |
|
2022-04-19 09:13 |
|
Publish the Manuscript Online |
|
2022-05-13 08:46 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Basri Satilmis, Gizem Selen Cicek, Egemen Cicek, Sami Akbulut, Tevfik Tolga Sahin and Sezai Yilmaz |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| none |
|
|
| Corresponding Author |
Tevfik Tolga Sahin, FACS, MD, PhD, Professor, Hepatology Research Laboratory, Liver Transplant Institute, Inonu University , Battalgazi Malatya , Malatya 44000, Battalgazi, Türkiye. tevfiktolgaa@gmail.com |
| Key Words |
Adipose-derived stem cells; Hepatobiliary diseases; Sepsis; Mesenchymal stem cells; Theoretic application |
| Core Tip |
Adipose-derived mesenchymal stem cells (AD-MSC) are mesenchymal stem cells that have pluripotent lineage characteristics. They are easily accessible, and the fraction of stem cells in the adipose tissue lysates is the highest among all other sources of mesenchymal stem cells. It is also HLA-DR negative and can be transplanted allogenically without the need for immunosuppression. We clearly need alternative therapeutic approaches to treat end-stage liver failure. AD-MSC can provide a means of bridge therapy to definitive therapeutic alternatives such as liver transplantation. We review the theoretic applications of AD-MSC in the treatment of hepatobiliary diseases. |
| Publish Date |
2022-05-13 08:46 |
| Citation |
Satilmis B, Cicek GS, Cicek E, Akbulut S, Sahin TT, Yilmaz S. Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis. World J Clin Cases 2022; 10(14): 4348-4356 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i14/4348.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i14.4348 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
